TY - CHAP M1 - Book, Section TI - Psychosocial Approaches to Pain A1 - Novy, Diane A1 - Veldhoven, Laura M. van A2 - Duffy, James D. A2 - Valentine, Alan D. PY - 2016 T2 - MD Anderson Manual of Psychosocial Oncology AB - Cancer-related pain may be experienced by 50% to 90% of patients with cancer.1 Cancer pain shares the same neuropathophysiological pathways as non-cancer pain; however, it rarely presents as a pure neuropathic, visceral, or somatic pain syndrome. Rather, it may involve inflammatory, neuropathy, ischemic, and compression mechanisms in multiple sites. Cancer pain may be attributed to tumor progression and invasion, cancer-related surgeries and therapeutic procedures, antineoplastic chemotherapy, hormone therapy, or radiotherapy, cancer-related infections, and musculoskeletal complaints related to inactivity and generalized fatigue.2 Cancer survivors may have persistent pain as a result of the disease or its treatment.3 Not only affecting quality of life, but also being an important predictor of survival, cancer pain is considered to be a pathogen that can further the progression of metastatic disease.4,5 SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/03/29 UR - hemonc.mhmedical.com/content.aspx?aid=1125785706 ER -